Something that happened or was uncovered recently anywhere in the world. It doesn't have to have global implications. Just has to be informative in some way.
Title format
Post title should mirror the news source title.
URL format
Post URL should be the original link to the article (even if paywalled) and archived copies left in the body. It allows avoiding duplicate posts when cross-posting.
[Opinion] prefix
Opinion (op-ed) articles must use [Opinion] prefix before the title.
1. English only
Title and associated content has to be in English.
2. No social media posts
Avoid all social media posts. Try searching for a source that has a written article or transcription on the subject.
3. Respectful communication
All communication has to be respectful of differing opinions, viewpoints, and experiences.
4. Inclusivity
Everyone is welcome here regardless of age, body size, visible or invisible disability, ethnicity, sex characteristics, gender identity and expression, education, socio-economic status, nationality, personal appearance, race, caste, color, religion, or sexual identity and orientation.
5. Ad hominem attacks
Any kind of personal attacks are expressly forbidden. If you can't argue your position without attacking a person's character, you already lost the argument.
6. Off-topic tangents
Stay on topic. Keep it relevant.
7. Instance rules may apply
If something is not covered by community rules, but are against lemmy.zip instance rules, they will be enforced.
Icon attribution | Banner attribution
I heard a podcast about this, and apparently, the study that was submitted was kind of flawed and had some testimony against it from the participants who had a bad experience.
If I were to guess, a better study would probably sway the FDA a little bit more, should one be presented.
Mind saying what podcast? I’d like to listen.
I listen to several a day, so I forgot which— possibly NPR’s Up First from yesterday?
the potential risk for heart problems, injury and abuse
We have to remember that post-hydrocodone, the FDA is wary about randomly approving drugs that "might help" but have the tendency to be habit forming.
There's a good reason for this vote.
The FDA is no fun when it comes to drugs.
MDMA didn't have a lobbyist group in its favor, otherwise we'd probably be all aware of the reality of effects like Oxycontin.
It's not horribly physically addictive, so lobbyists aren't interested.